Roland Frank

Title: The Innovative Contributions of Roland Frank

Introduction

Roland Frank is a notable inventor based in Meine, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of proliferative diseases. His work focuses on the use of specific inhibitors that target the degradation of p27, a crucial protein in cell cycle regulation.

Latest Patents

Roland Frank holds a patent for the "Use of inhibitors of the degradation of p27, in particular Argyrin and derivatives thereof, for the treatment of proliferative diseases." This invention relates to the application of particular macrocycles that inhibit the proteasomic degradation of p27, specifically Argyrin and its derivatives, such as Argyrin A. The patent addresses the potential treatment of proliferative diseases, including cancer, and explores the derivatization of these macrocycles. He has 1 patent to his name.

Career Highlights

Throughout his career, Roland Frank has worked with esteemed institutions, including Helmholtz-Zentrum für Infektionsforschung GmbH and Medizinische Hochschule Hannover. His research has contributed to advancements in understanding and treating various diseases.

Collaborations

Roland has collaborated with notable colleagues, including Nisar Malek and Florenz Sasse. Their combined expertise has furthered the impact of his research in the scientific community.

Conclusion

Roland Frank's innovative work in the field of medical research highlights his commitment to addressing critical health challenges. His contributions, particularly in the treatment of proliferative diseases, underscore the importance of continued research and innovation in medicine.